278 related articles for article (PubMed ID: 28635664)
1. Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.
Aguilar MA; Ledesma JC; Rodríguez-Arias M; Penalva C; Manzanedo C; Miñarro J; Arenas MC
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635664
[TBL] [Abstract][Full Text] [Related]
2. Adolescent but not adult ethanol binge drinking modulates cocaine withdrawal symptoms in mice.
Ledesma JC; Aguilar MA; Giménez-Gómez P; Miñarro J; Rodríguez-Arias M
PLoS One; 2017; 12(3):e0172956. PubMed ID: 28291777
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
4. Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood.
Kononoff J; Melas PA; Kallupi M; de Guglielmo G; Kimbrough A; Scherma M; Fadda P; Kandel DB; Kandel ER; George O
Sci Rep; 2018 Sep; 8(1):13893. PubMed ID: 30224774
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cannabinoid Exposure during Adolescence on the Conditioned Rewarding Effects of WIN 55212-2 and Cocaine in Mice: Influence of the Novelty-Seeking Trait.
Rodríguez-Arias M; Roger-Sánchez C; Vilanova I; Revert N; Manzanedo C; Miñarro J; Aguilar MA
Neural Plast; 2016; 2016():6481862. PubMed ID: 26881125
[TBL] [Abstract][Full Text] [Related]
6. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.
Schneider M; Schömig E; Leweke FM
Addict Biol; 2008 Sep; 13(3-4):345-57. PubMed ID: 18782382
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
Cagni P; Barros M
Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
[TBL] [Abstract][Full Text] [Related]
9. Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory.
Kirschmann EK; Pollock MW; Nagarajan V; Torregrossa MM
Neuropsychopharmacology; 2017 Apr; 42(5):989-1000. PubMed ID: 27582345
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid type-1 receptor ligands, alone or in combination with cocaine, affect vigilance-related behaviors of marmoset monkeys.
Cagni P; Melo GC; de Jesus AG; Barros M
Brain Res; 2014 Mar; 1550():27-35. PubMed ID: 24445195
[TBL] [Abstract][Full Text] [Related]
11. Chronic and acute adenosine A
Mouro FM; Batalha VL; Ferreira DG; Coelho JE; Baqi Y; Müller CE; Lopes LV; Ribeiro JA; Sebastião AM
Neuropharmacology; 2017 May; 117():316-327. PubMed ID: 28235548
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
Zhang RS; He Z; Jin WD; Wang R
Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
[TBL] [Abstract][Full Text] [Related]
13. Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.
Brewer AL; Felter CE; Sternitzky AR; Spencer SM
Pharmacol Biochem Behav; 2024 Mar; 236():173707. PubMed ID: 38244864
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.
Hajizadeh Moghaddam A; Bigdellu R; Fatemi Tabatabaei SR; Roohbakhsh A
Arch Iran Med; 2013 Dec; 16(12):711-6. PubMed ID: 24329144
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR
Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139
[TBL] [Abstract][Full Text] [Related]
16. Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood.
Pérez-Valenzuela EJ; Andrés Coke ME; Grace AA; Fuentealba Evans JA
Int J Neuropsychopharmacol; 2020 Dec; 23(9):626-637. PubMed ID: 32710782
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2.
Schneider M; Drews E; Koch M
Behav Pharmacol; 2005 Sep; 16(5-6):447-54. PubMed ID: 16148450
[TBL] [Abstract][Full Text] [Related]
18. Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence.
Dong C; Tian Z; Zhang K; Chang L; Qu Y; Pu Y; Ren Q; Fujita Y; Ohgi Y; Futamura T; Hashimoto K
Pharmacol Biochem Behav; 2019 Feb; 177():61-68. PubMed ID: 30629965
[TBL] [Abstract][Full Text] [Related]
19. The CB1 receptor agonist, WIN 55,212-2, dose-dependently disrupts object recognition memory in adult rats.
Baek Jh; Zheng Y; Darlington CL; Smith PF
Neurosci Lett; 2009 Oct; 464(1):71-3. PubMed ID: 19666083
[TBL] [Abstract][Full Text] [Related]
20. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
Radziszewska E; Bojanowska E
Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
